Kudolo G B, Harper M J
Department of Medicine, University of Texas Health Science Center, San Antonio 78284, USA.
J Lipid Mediat Cell Signal. 1995 Mar;11(2):145-58. doi: 10.1016/0929-7855(94)00034-a.
Endometrial platelet-activating factor (PAF, 1-O-alkyl-2-acetyl-sn-glycero-3-phosphorylcholine) levels change significantly during the pre-implantation period in the rabbit uterus, but under in vitro culture conditions, constitutive PAF biosynthesis by isolated endometrial tissues is not easily demonstrable. Rapid metabolism of PAF relative to its synthesis may account for this disparity because we have recently shown that in stromal cells there is a significant build-up of lyso-PAF suggesting that lyso-PAF-acetyl-CoA acetyltransferase might be a limiting factor. In the glandular epithelial cells however, the lyso-PAF build-up was replaced by a significant accumulation of a neutral lipid which was tentatively identified as 1-O-hexadecyl-2-acetylglycerol. It was hypothesized that, during endometrial growth and development, this lipid might serve as the substrate for the alkylacetylglycerol CDP-choline cholinephosphotransferase enzyme for PAF synthesis via the de novo pathway. We have therefore examined the activities of lyso-PAF:acetyl-CoA acetyltransferase and the CDP-cholinephosphotransferase enzymes. Microsomal preparations containing lyso-PAF:acetyl-CoA acetyltransferase activity catalyzed the incorporation of [3H]acetyl-CoA lyso-PAF into two distinct lipid products. One co-migrated with authentic PAF and the other with 1-O-hexadecyl-2-acetylglycerol, the latter being formed subsequent to PAF formation. The alkylacetylglycerol CDP-choline cholinephosphotransferase enzyme, which would potentially utilize the alkylacetylglycerol synthesized via the remodeling pathway, was also demonstrable. Unlike the species present in other tissues however, it was found to be sensitive to the presence of 10 mM DTT. The diacylglycerol CDP-choline cholinephosphotransferase species was also demonstrable and supported the synthesis of both PAF and phosphatidylcholine, in the absence of DTT, when only the synthesis of phosphatidylcholine was expected. It is hypothesized that the rabbit endometrium possesses active enzymes which may catalyze PAF synthesis via both the de novo and 'remodeling' pathways.
在兔子宫植入前期,子宫内膜血小板活化因子(PAF,1-O-烷基-2-乙酰基-sn-甘油-3-磷酸胆碱)水平发生显著变化,但在体外培养条件下,分离的子宫内膜组织中PAF的组成型生物合成不易被证实。PAF相对于其合成的快速代谢可能解释了这种差异,因为我们最近发现,在基质细胞中溶血PAF有显著积累,这表明溶血PAF-乙酰辅酶A乙酰转移酶可能是一个限制因素。然而,在腺上皮细胞中,溶血PAF的积累被一种中性脂质的显著积累所取代,这种中性脂质初步鉴定为1-O-十六烷基-2-乙酰甘油。据推测,在子宫内膜生长和发育过程中,这种脂质可能作为烷基乙酰甘油CDP-胆碱胆碱磷酸转移酶的底物,通过从头合成途径合成PAF。因此,我们检测了溶血PAF:乙酰辅酶A乙酰转移酶和CDP-胆碱磷酸转移酶的活性。含有溶血PAF:乙酰辅酶A乙酰转移酶活性的微粒体制剂催化[3H]乙酰辅酶A溶血PAF掺入两种不同的脂质产物中。一种与纯PAF共迁移,另一种与1-O-十六烷基-2-乙酰甘油共迁移,后者在PAF形成后形成。也证实了烷基乙酰甘油CDP-胆碱胆碱磷酸转移酶,该酶可能利用通过重塑途径合成的烷基乙酰甘油。然而,与其他组织中存在的酶不同,发现它对10 mM DTT的存在敏感。二酰基甘油CDP-胆碱胆碱磷酸转移酶也得到了证实,并且在没有DTT的情况下,支持了PAF和磷脂酰胆碱的合成,而此时预计只会合成磷脂酰胆碱。据推测,兔子宫内膜拥有活性酶,这些酶可能通过从头合成途径和“重塑”途径催化PAF的合成。